Nicholas Vogelzang, MD, Joins US Oncology Research Network via Comprehensive Cancer Centers...(er and testicular cancer and for mesothe...),Health

Prior to joining the US Oncology Research network and CCCN, Dr. Vogelzang served as a faculty member at the University of Chicago and later as the director of the University of Chicago Cancer Research Center. In 2004, he joined the Nevada Cancer Institute as its director.

"Many arms make light work," says Dr. Vogelzang. "The US Oncology Research network provides many arms and eager hands to make the research system readily available to multiple patients across the country. Joining the network provides three great opportunities: greater access to clinical trials, a greater opportunity for translational research and a greater opportunity for inclusiveness of all oncology medical fields into the research, including surgeons, medical oncologists, hematologists and radiation oncologists."

US Oncology Research currently has more than 70 open clinical trials in more than 80 sites across 200 locations. US Oncology Research can be accessed by community-based oncology practices in a variety of ways, including access through its electronic health record system, iKnowMed, which is available to oncologists inside and outside of the US Oncology network of physicians. For more information, visit www.usoncology.com.

About US Oncology Research

With experienced investigators and dedicated research nurses, US Oncology Research represents the largest research network specializing in Phase I-IV oncology clinical trials in the United States. US Oncology Research serves more than 80 sites in 200 locations with over 70 open trials being managed at any given time.

Additionally, the
'/>"/>